Interherence is a Germany-based biotechnology startup founded in 2020 with a mission to bring high sensitivity microscopy to everyone. Their flagship product, QuScite, is the first commercial implementation of waveguide-based TIRF microscopy, offering high and super resolution capabilities. Additionally, they offer VAHEAT, a miniaturized temperature controller for microscopy, demonstrating the company's focus on ease of use and increased experimental reproducibility. Interherence emphasizes custom solutions and OEM partnerships, highlighting their adaptability to diverse customer needs. Despite no publicly disclosed recent investments, the potential for growth and innovation in the optical microscopy market positions Interherence as an intriguing prospect for venture capital investment.
There is no investment information
No recent news or press coverage available for Interherence.